Intern Survival Series Lecture #9 Renal Insufficiency Shaping the - - PowerPoint PPT Presentation

intern survival series lecture 9
SMART_READER_LITE
LIVE PREVIEW

Intern Survival Series Lecture #9 Renal Insufficiency Shaping the - - PowerPoint PPT Presentation

Intern Survival Series Lecture #9 Renal Insufficiency Shaping the Future of Healthcare | www.thewrightcenter.org Goals and Objectives Be able to recognize the various types of renal disease, and initiate an appropriate workup Be able to


slide-1
SLIDE 1

Shaping the Future of Healthcare | www.thewrightcenter.org

Intern Survival Series Lecture #9

Renal Insufficiency

slide-2
SLIDE 2

Shaping the Future of Healthcare | www.thewrightcenter.org

Goals and Objectives

  • Be able to recognize the various types of renal

disease, and initiate an appropriate workup

  • Be able to recognize signs and symptoms of

Hyperkalemia and address it with appropriate treatment modalities

slide-3
SLIDE 3

Shaping the Future of Healthcare | www.thewrightcenter.org

A Brief Note

  • This lecture series is not meant to be all inclusive
  • r totally comprehensive to all of internal

medicine

  • It is not meant to supersede clinical judgment
  • It is not meant to replace daily reading or bedside

teaching

  • It is meant to act as a starting point for which to

grow from as new primary care physicians

  • It is a tool to help you survive the your new job
slide-4
SLIDE 4

Shaping the Future of Healthcare | www.thewrightcenter.org

Most Frequent Primary Care, Inpatient Diagnosis

  • 1)Pneumonia
  • 2)Congestive Heart Failure
  • 3)Osteoarthritis
  • 4)Coronary Artery Disease
  • 5)Septicemia
  • 6)Cardiac Dysrhythmias
  • 7)Chronic Obstructive Pulmonary Disease
slide-5
SLIDE 5

Shaping the Future of Healthcare | www.thewrightcenter.org

Fastest Growing Inpatient Diagnosis in Medicine

  • 1)Acute Renal Failure
  • 2)Anemia
  • 3)Diabetes Mellitus
  • 4)Malaise and Fatigue
  • 5)Pulmonary Heart Disease
slide-6
SLIDE 6

Shaping the Future of Healthcare | www.thewrightcenter.org

Most Common Secondary Diagnosis

  • 1)Hypertension
  • 2)Hyperlipidemia
  • 3)Fluid and electrolyte disorders
  • 4)Coronary Atherosclerosis
  • 5)Diabetes Mellitus
  • 6)Anemia
  • 7)Cardiac Dysrhythmias
  • 8)Esophageal Disorders
slide-7
SLIDE 7

Shaping the Future of Healthcare | www.thewrightcenter.org

Kidney Disease

  • About 20 million Americans have kidney disease.
  • The number of people diagnosed with kidney

disease has doubled each decade for the last two decades

  • Diabetes and hypertension (high blood pressure)

are the number one and number two causes of kidney disease, respectively.

  • Diabetes accounts for 35% of all new ESRD cases
slide-8
SLIDE 8

Shaping the Future of Healthcare | www.thewrightcenter.org

Renal Failure

  • Acute Renal Failure

– Now referred to as acute kidney injury – abrupt and usually reversible decline in the GFR. – Develops in hours to days – Can develop into rapidly progressing renal failure

  • Kidney disease that

progresses for weeks

  • Chronic Renal Failure

– Now referred to as chronic kidney disease – A glomerular filtration rate less than 60 mL/min for three months or more – and/or evidence of kidney damage

  • albuminuria
  • urine sediment abnormalities
  • findings on renal imaging or

renal biopsy

slide-9
SLIDE 9

Shaping the Future of Healthcare | www.thewrightcenter.org

AKI Incidence

  • The number of

hospitalizations that included an AKI diagnosis rose from 3,942 in 1996 to 23,052 in 2008.

slide-10
SLIDE 10

Shaping the Future of Healthcare | www.thewrightcenter.org

Common Causes of AKI

  • Acute tubular necrosis (ATN)

– Most common cause in hospitalized patients

  • Ischemia
  • nephrotoxin exposure
  • sepsis
  • Volume Depletion
  • Urinary Obstruction
  • Rapidly Progressive Glomerulonephritis
  • Acute Interstitial Nephritis
slide-11
SLIDE 11

Shaping the Future of Healthcare | www.thewrightcenter.org

Defining AKI

KDIGO criteria (Kidney Disease Improving Global Outcomes)

  • An increase in serum creatinine of ≥0.3 mg/dL

(≥26.5 micromol/L) within 48 hours

  • An increase in serum creatinine of ≥1.5 times

baseline, which is known or presumed to have

  • ccurred within the prior 7 days; or
  • Urine volume <0.5 mL/kg per hour for more

than 6 hours

slide-12
SLIDE 12

Shaping the Future of Healthcare | www.thewrightcenter.org

Staging AKI

  • Stage 1 AKI

– increase in the serum creatinine of 1.5 to 1.9 times baseline OR – serum creatinine increase of ≥0.3 mg/dL OR – urine output <0.5 mL/kg per hour for 6 to 12 hours.

slide-13
SLIDE 13

Shaping the Future of Healthcare | www.thewrightcenter.org

Staging AKI

  • Stage 2 AKI

– increase in the serum creatinine of 2.0 to 2.9 times baseline OR – urine output <0.5 mL/kg per hour for ≥12 hours.

slide-14
SLIDE 14

Shaping the Future of Healthcare | www.thewrightcenter.org

Staging AKI

  • Stage 3 AKI

– increase in the serum creatinine of 3x baseline OR – increase in serum creatinine to ≥4.0 OR – urine output of <0.3 mL/kg per hour for ≥24 hours, OR – anuria for ≥12 hours OR – the initiation of renal replacement therapy OR, – in patients <18 years, decrease in estimated GFR to <35 mL/min

slide-15
SLIDE 15

Shaping the Future of Healthcare | www.thewrightcenter.org

AKI Workup

  • UA
  • Strict I/Os, daily weights
  • Urine Electrolytes

– Urine Na, K, Cr

  • Renal Imaging to assess for

– urinary tract obstruction – kidney stones – renal cyst or mass – renal vascular diseases

slide-16
SLIDE 16

Shaping the Future of Healthcare | www.thewrightcenter.org

Fractional Excretion of Na

  • The FENa is the most accurate screening test

to differentiate between prerenal disease and ATN.

  • A value below 1 percent suggests prerenal

disease

  • A value above 2 percent usually indicates ATN
  • A value between 1 and 2 percent can be seen

with either disorde

slide-17
SLIDE 17

Shaping the Future of Healthcare | www.thewrightcenter.org

FENa

slide-18
SLIDE 18

Shaping the Future of Healthcare | www.thewrightcenter.org

FENa

  • Be aware that there are limitations to FENa
  • Some examples (but not all)

– The FENa may remain below 1 percent when ATN is superimposed upon a chronic prerenal disease – Diuretics can raise the FENa, even in patients with prerenal disease giving misleading numbers – A low FENa is not unique to prerenal disease, and can be seen in:

  • Acute glomerulonephritis
  • Vasculitis
  • Contrast-induced nephropathy.
slide-19
SLIDE 19

Shaping the Future of Healthcare | www.thewrightcenter.org

slide-20
SLIDE 20

Shaping the Future of Healthcare | www.thewrightcenter.org

Complications of AKI

  • Fluid overload
  • Hyperkalemia or a rapidly increasing serum

potassium

  • Signs of uremia, such as pericarditis, or an
  • therwise unexplained decline in mental

status

  • Severe metabolic acidosis (pH less than 7.1)
slide-21
SLIDE 21

Shaping the Future of Healthcare | www.thewrightcenter.org

Hyperkalemia

  • The urgency of treatment of hyperkalemia

varies with the cause and the presence or absence of the symptoms and signs associated with hyperkalemia.

– muscle weakness or paralysis – cardiac conduction abnormalities – cardiac arrhythmias

slide-22
SLIDE 22

Shaping the Future of Healthcare | www.thewrightcenter.org

Call from Tele

  • Patient’s Rhythm strip is

showing some abnormalities…..

slide-23
SLIDE 23

Shaping the Future of Healthcare | www.thewrightcenter.org

slide-24
SLIDE 24

Shaping the Future of Healthcare | www.thewrightcenter.org

slide-25
SLIDE 25

Shaping the Future of Healthcare | www.thewrightcenter.org

Hyperkalemia

slide-26
SLIDE 26

Shaping the Future of Healthcare | www.thewrightcenter.org #1 Peak T waves #2 Increased PR intervals #3 Increased QRS #4 Loss of P waves #5 SINE Waves

slide-27
SLIDE 27

Shaping the Future of Healthcare | www.thewrightcenter.org

Hyperkalemia Treatment

Rapid Acting Treatment Indications

  • Patients with hyperkalemia and electrocardiographic changes
  • Patients with a serum potassium greater than 6.5 to 7 meq/L

– Ok to wait if potassium is ≥7.0 meq/L in patients who have no clinical or electrocardiographic signs of hyperkalemia, use clinical judgment

  • Ok to give rapid acting analogs in patients with a serum

potassium that is rapidly increasing, but again, use clinical judgment

slide-28
SLIDE 28

Shaping the Future of Healthcare | www.thewrightcenter.org

Hyperkalemia

  • Rapid Treatment

– Calcium Gluconate

  • 1 ampoule, infused over two to three minutes, with

constant cardiac monitoring

  • Stabilized the myocardium
  • can be repeated after five minutes if the ECG changes

persist or recur

slide-29
SLIDE 29

Shaping the Future of Healthcare | www.thewrightcenter.org

Hyperkalemia

  • Rapid Treatment

– Insulin with dextrose

  • 10units of regular insulin in 500ml D10W over 1hr

– Begins to work in 10-20mins, lasts 4-6 hours

  • If Serum Glucose >250 ~ 10 Units only
  • If Serum Glucose <250, but still on high side can give 10 unit

insulin bolus w 50ml of 50% dextrose

  • asdf
slide-30
SLIDE 30

Shaping the Future of Healthcare | www.thewrightcenter.org

Hyperkalemia

Rapid Treatment

– Albuterol Nebulizers – Bicarb

  • Mostly ineffective, but in hypovolemic patients it is ok to give One liter of

½ NS with 75 Units of Bicarb

– Hemodialysis

slide-31
SLIDE 31

Shaping the Future of Healthcare | www.thewrightcenter.org

Hemodialysis Indications

  • Acid base disorders

– i.e. Severe Metabolic Acidosis

  • Electrolytes

– i.e. Hyperkalemia

  • Intoxication

– i.e Lithium, Ethylene Glycol

  • Overload

– Fluid Overload, not responding to diuretics

  • Uremia

– Usually seen in patients with BUN>100

slide-32
SLIDE 32

Shaping the Future of Healthcare | www.thewrightcenter.org

Chronic Kidney Disease

  • Defined as the presence of kidney

damage or decreased kidney function for three or more months

  • irrespective of the cause
  • Decreased kidney function is identified in

most cases by an eGFR less than 60 mL/min

slide-33
SLIDE 33

Shaping the Future of Healthcare | www.thewrightcenter.org

CKD

  • Kidney damage is identified in most cases by

the presence of:

– albuminuria – urinary sediment abnormalities – anatomic abnormalities discovered with imaging studies – pathologic abnormalities discovered with kidney biopsy – a history of kidney transplantation

slide-34
SLIDE 34

Shaping the Future of Healthcare | www.thewrightcenter.org

CKD Staging

  • The purpose of CKD staging is to guide

management, including risk for progression and complications of CKD

slide-35
SLIDE 35

Shaping the Future of Healthcare | www.thewrightcenter.org

CKD Staging

slide-36
SLIDE 36

Shaping the Future of Healthcare | www.thewrightcenter.org

slide-37
SLIDE 37

Shaping the Future of Healthcare | www.thewrightcenter.org

  • Questions?